213 related articles for article (PubMed ID: 33289967)
1. Impact of socio-economic deprivation on endometrial cancer survival in the North West of England: a prospective database analysis.
Njoku K; Barr CE; Hotchkies L; Quille N; Wan YL; Crosbie EJ
BJOG; 2021 Jun; 128(7):1215-1224. PubMed ID: 33289967
[TBL] [Abstract][Full Text] [Related]
2. Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis.
Njoku K; Ramchander NC; Wan YL; Barr CE; Crosbie EJ
Gynecol Oncol; 2022 Jan; 164(1):146-153. PubMed ID: 34802721
[TBL] [Abstract][Full Text] [Related]
3. Effect of deprivation on in vitro fertilisation outcome: a cohort study.
Richardson AL; Baskind NE; Karuppusami R; Balen AH
BJOG; 2020 Mar; 127(4):458-465. PubMed ID: 31715078
[TBL] [Abstract][Full Text] [Related]
4. Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis.
Njoku K; Barr CE; Ramchander NC; Crosbie EJ
PLoS One; 2022; 17(8):e0272232. PubMed ID: 35925991
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic deprivation and survival in endometrial cancer: The effect of BMI.
Donkers H; Bekkers R; Massuger L; Galaal K
Gynecol Oncol; 2020 Jan; 156(1):178-184. PubMed ID: 31759773
[TBL] [Abstract][Full Text] [Related]
6. Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis.
Njoku K; Agnew HJ; Crosbie EJ
Front Oncol; 2022; 12():899262. PubMed ID: 35600348
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; D'Amico R; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Gribaudo S; Provencher D; Hanzen C; Kruitwagen RF; Smit VTHBM; Singh N; Do V; Lissoni A; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2019 Sep; 20(9):1273-1285. PubMed ID: 31345626
[TBL] [Abstract][Full Text] [Related]
8. Socio-economic inequalities in survival from screen-detected breast cancer in South West England: population-based cohort study.
McKenzie F; Ives A; Jeffreys M
Eur J Public Health; 2012 Jun; 22(3):418-22. PubMed ID: 21891789
[TBL] [Abstract][Full Text] [Related]
9. Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
Kontopantelis E; Mamas MA; Webb RT; Castro A; Rutter MK; Gale CP; Ashcroft DM; Pierce M; Abel KM; Price G; Faivre-Finn C; Van Spall HGC; Graham MM; Morciano M; Martin GP; Sutton M; Doran T
PLoS Med; 2022 Feb; 19(2):e1003904. PubMed ID: 35167587
[TBL] [Abstract][Full Text] [Related]
10. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of Outcomes Following Laparoscopic and Open Hysterectomy With or Without Lymphadenectomy for Presumed Early-Stage Endometrial Cancer: Results From the Medical Research Council ASTEC Trial.
Kyrgiou M; Swart AM; Qian W; Warwick J
Int J Gynecol Cancer; 2015 Oct; 25(8):1424-36. PubMed ID: 26244758
[TBL] [Abstract][Full Text] [Related]
13. Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey.
Lindemann K; Cvancarova M; Eskild A
Gynecol Oncol; 2015 Dec; 139(3):476-80. PubMed ID: 26434365
[TBL] [Abstract][Full Text] [Related]
14. The role of adjuvant radiotherapy in stage I endometrial cancer: A single-institution outcome.
Lin YJ; Hu YW; Twu NF; Liu YM
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):604-609. PubMed ID: 31542079
[TBL] [Abstract][Full Text] [Related]
15. The influence of comorbid conditions on racial disparities in endometrial cancer survival.
Ruterbusch JJ; Ali-Fehmi R; Olson SH; Sealy-Jefferson S; Rybicki BA; Hensley-Alford S; Elshaikh MA; Gaba AR; Schultz D; Munkarah AR; Cote ML
Am J Obstet Gynecol; 2014 Dec; 211(6):627.e1-9. PubMed ID: 24954655
[TBL] [Abstract][Full Text] [Related]
16. Inequalities in hip fracture incidence are greatest in the North of England: regional analysis of the effects of social deprivation on hip fracture incidence across England.
Bhimjiyani A; Neuburger J; Jones T; Ben-Shlomo Y; Gregson CL
Public Health; 2018 Sep; 162():25-31. PubMed ID: 29945041
[TBL] [Abstract][Full Text] [Related]
17. Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England.
Ling S; Zaccardi F; Issa E; Davies MJ; Khunti K; Brown K
Diabetologia; 2023 Apr; 66(4):657-673. PubMed ID: 36690836
[TBL] [Abstract][Full Text] [Related]
18. What might explain deprivation-specific differences in the excess hazard of breast cancer death amongst screen-detected women? Analysis of patients diagnosed in the West Midlands region of England from 1989 to 2011.
Morris M; Woods LM; Rachet B
Oncotarget; 2016 Aug; 7(31):49939-49947. PubMed ID: 27363022
[TBL] [Abstract][Full Text] [Related]
19. The impact of race, comorbid conditions and obesity on survival endpoints in women with high grade endometrial carcinoma.
Fucinari J; Elshaikh MA; Ruterbusch JJ; Khalil R; Dyson G; Shultz D; Ali-Fehmi R; Cote ML
Gynecol Oncol; 2021 Jul; 162(1):134-141. PubMed ID: 33985795
[TBL] [Abstract][Full Text] [Related]
20. Thirty-day postoperative mortality for endometrial carcinoma in England: a population-based study.
Gildea C; Nordin A; Hirschowitz L; Poole J
BJOG; 2016 Oct; 123(11):1853-61. PubMed ID: 26924123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
